Study risk factors in progressive lung scarring
Part of Lungs & breathing clinical trials.
This study looks at what factors contribute to worsening lung scarring seen on scans in people with certain lung diseases. Results may help doctors better understand and predict who will worsen over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You can read, agree with, and sign the consent form
- Your lung scan shows lung scarring (pulmonary fibrosis) from an interstitial lung disease
- You do not have idiopathic pulmonary fibrosis (IPF) specifically
- You are not pregnant or breastfeeding
- You have no serious mental illness or memory/cognitive problems that would prevent consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with a specific type of lung scarring (not IPF) to understand how the disease progresses. Researchers will collect detailed health information, imaging, and blood samples to learn more about the condition.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study follows people with systemic sclerosis who also have lung scarring (interstitial lung disease). It aims to map how lung function and lung images change over time, which may help doctors predict and better manage disease progression.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.